SBRA Stock Analysis — Sabra Health Care REIT
Sector: Healthcare REIT
AI Verdict
You're paying up for a narrative of accelerating earnings growth, but the premium only makes sense if SBRA's diversified lease base keeps delivering.
Competitive Moat
Sabra owns and leases a diversified portfolio of senior housing and skilled nursing facilities, benefiting from long-term demographic tailwinds and tenant diversification that reduce single-operator risk. The scale and contractual lease structures provide some insulation from short-term operating volatility.
Summary
SBRA stands out for its 19.5% expected EPS growth and a forward P/E of 28.1x, outpacing most healthcare REIT peers.
Where It Stands
Shares trade at 28.1x next year's earnings versus a healthcare sector median of 22x, with trailing EPS growth of 19.5% and a trailing P/E of 33.6x.
Key Metrics
- Trailing P/E: 33.6x
- Forward P/E: 28.1x
- PEG Ratio: 1.72
- Earnings Growth: +0.2%
- Revenue Growth: +0.1%
- Dividend Yield: 0.06%
- 52-Week High: $21.07
- 52-Week Low: $17.08
Analyst Consensus
11 Buy · 9 Hold · 0 Sell (20 analysts)
Bull Case
Analysts expect 19.5% EPS growth next year, which makes the 28.1x forward P/E look reasonable for a REIT with stable, long-term lease income.
Bear Case
If the P/E multiple falls from 28.1x to the sector median of 22x, the stock could lose roughly 22% even if earnings hit targets.
Catalyst to Watch
Watch for quarterly tenant performance updates — any sign of lease defaults or weaker rent coverage could force a re-rating.